Trial Type: Brain Tumors (Pediatric)

PHO-TEaM – (BCC16)
Phase II Trial of Eflornithine/DFMO as Maintenance Therapy for Molecular High Risk/Very High Risk and Relapsed/Refractory Medulloblastoma
Status: Open
Contact: Jennifer Welch, MD
ACNS1723
A Phase 2 Study of Dabrafenib (NSC# 763760) with Trametinib (NSC# 763093) after Local Irradiation in Newly Diagnosed BRAFV600-Mutant High-Grade Glioma (HGG) (IND# 145355)
Status: Open
Contact: Sasmit Sarangi, MD
Phase 2 Trial of Chemotherapy
A Phase 2 Trial of Chemotherapy followed by Response-Based Whole Ventricular & Spinal Canal Irradiation (WVSCI) for Patients with Localized Non-Germinomatous Central Nervous System Germ Cell Tumor
Status: Open
Contact: Jennifer Welch, MD
Phase 3 Study of Carboplatin and Vincristine
A Phase 3 Study of Carboplatin and Vincristine versus Selumetinib) in Newly Diagnosed or Previously Untreated Low-Grade Glioma (LGG) not associated with BRAFV600E Mutations or Systemic Neurofibromatosis Type 1 (NF1)
Status: Open
Contact: Jennifer Welch, MD
KPT-330
A Phase 1/2 Trial of Selinexor (KPT-330) and Radiation Therapy for Newly Diagnosed DIPG and High Grade Glioma
Status: Open
Contact: Jennifer Welch, MD